SAGE Journal Articles

Click on the following links. Please note these will open in a new window.

Article 1: Factitious Disorder in Intensive Care Unit: Are We Doing Enough?

Abstract: A 23-year-old woman presented with clinical signs and symptoms suggestive of acute severe asthma requiring intensive care admission. She was later diagnosed to have factitious disorder. This case report highlights the importance of diagnosing factitious disorder in the intensive care unit and the teamwork required in dealing with such cases to prevent recurrence, mortality and litigation.

Questions to Consider

  1. What were some warning signs that this person might have factitious disorder, in her report of medical history?
  2. Why might the risk of death be higher for people with factitious disorder than for those with psychosis?
  3. How might it be beneficial to view the patient’s behavior as a form of self-harming behavior?
     

Article 2: A Placebo-Controlled, Cross-Over Trial of Lamotrigine in Depersonalization Disorder

Abstract: There is evidence to support the view that glutamate hyperactivity might be relevant to the neurobiology of depersonalization. We tested the efficacy of lamotrigine, which reduces glutamate release, as a treatment for patients with depersonalization disorder. A double-blind, placebo-controlled, cross-over design was used to evaluate 12 weeks of treatment of lamotrigine. Subjects comprised nine patients with DSM-IV depersonalization disorder. Changes on the Cambridge Depersonalization Scale and the Present State Examination depersonalization/derealization items were compared across the two cross-over periods. Lamotrigine was not significantly superior to placebo. None of the nine patients was deemed a responder to the lamotrigine arm of the cross-over. Lamotrigine does not seem to be useful as a sole medication in the treatment of depersonalization disorder.

Questions to Consider:

  1. Why was the double-blind, placebo-controlled, cross-over design the best research design for evaluating the effects of lamotrigine for depersonalization disorder?
  2. Five patients failed to complete this study. Does this attrition rate bias the study results?
  3. Why didn’t the researchers evaluate lamotrigine’s effect as an “add-on therapy” with SSRIs in this study?